Veracyte, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 30, 2025: USD 22.86 M

Veracyte, Inc. Depreciation And Amortization is USD 22.86 M for the Trailing 12 Months (TTM) ending June 30, 2025, a -8.53% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • Veracyte, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 30, 2024 was USD 24.99 M, a -5.38% change year over year.
  • Veracyte, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 30, 2023 was USD 26.41 M, a 3.20% change year over year.
  • Veracyte, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 30, 2022 was USD 25.59 M, a 131.28% change year over year.
  • Veracyte, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 30, 2021 was USD 11.06 M.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased